A detailed history of Mesirow Financial Investment Management, Inc. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 10,126 shares of SNDX stock, worth $132,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,126
Holding current value
$132,448
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$17.93 - $24.81 $181,559 - $251,226
10,126 New
10,126 $194,000
Q2 2024

Jul 16, 2024

BUY
$18.82 - $23.79 $232,332 - $293,687
12,345 New
12,345 $253 Million
Q1 2024

Apr 19, 2024

SELL
$19.71 - $24.57 $73,045 - $91,056
-3,706 Reduced 23.13%
12,318 $293 Million
Q4 2023

Jan 10, 2024

BUY
$11.39 - $21.67 $42,609 - $81,067
3,741 Added 30.46%
16,024 $346,000
Q2 2023

Jul 14, 2023

BUY
$19.35 - $22.31 $237,676 - $274,033
12,283 New
12,283 $257,000
Q2 2021

Jul 23, 2021

SELL
$13.42 - $25.18 $11,997 - $22,510
-894 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$19.28 - $24.59 $7,364 - $9,393
382 Added 74.61%
894 $20,000
Q4 2020

Jan 14, 2021

BUY
$15.1 - $26.44 $7,731 - $13,537
512 New
512 $11,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.